Bank of America Corp DE Trims Position in Amedisys, Inc. (NASDAQ:AMED)

Bank of America Corp DE decreased its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 74.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 87,087 shares of the health services provider’s stock after selling 256,675 shares during the period. Bank of America Corp DE owned 0.27% of Amedisys worth $7,907,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. grew its stake in shares of Amedisys by 12.2% in the fourth quarter. Ameriprise Financial Inc. now owns 38,009 shares of the health services provider’s stock valued at $3,451,000 after buying an additional 4,146 shares in the last quarter. AQR Arbitrage LLC raised its stake in shares of Amedisys by 59.1% during the fourth quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider’s stock valued at $42,812,000 after purchasing an additional 175,311 shares in the last quarter. Schonfeld Strategic Advisors LLC increased its stake in shares of Amedisys by 17.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 4,500 shares of the health services provider’s stock valued at $409,000 after acquiring an additional 671 shares during the period. Pentwater Capital Management LP raised its stake in shares of Amedisys by 178.3% in the 4th quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider’s stock worth $107,132,000 after buying an additional 756,000 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Amedisys by 23.6% during the 4th quarter. Northern Trust Corp now owns 289,228 shares of the health services provider’s stock valued at $26,259,000 after purchasing an additional 55,264 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Stock Performance

Shares of NASDAQ AMED opened at $93.43 on Monday. The business has a fifty day simple moving average of $93.36 and a 200 day simple moving average of $91.53. The firm has a market capitalization of $3.07 billion, a price-to-earnings ratio of 37.08, a PEG ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating the consensus estimate of $1.13 by $0.12. The company had revenue of $594.78 million for the quarter, compared to the consensus estimate of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.03 EPS. Sell-side analysts expect that Amedisys, Inc. will post 4.4 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on AMED shares. Wall Street Zen lowered Amedisys from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Royal Bank of Canada restated an “outperform” rating and set a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Finally, Stephens reissued an “equal weight” rating and set a $101.00 target price on shares of Amedisys in a research report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.